in collaboration with
Venture Capital &
International Growth
From Cyprus to the United States
Athlos House, Nicosia | 26 March 2026 | 17:00 – 19:00
Limited to 20 participants
Why Attend
We are hosting a small private gathering to discuss early-stage venture capital and how companies scale from Cyprus into the U.S. market.
Venture capital continues to shape global innovation, with the United States remaining its most mature and dynamic ecosystem. Yet from the outside, the space can often feel distant or difficult to assess.
This session is designed for private investors and professionals advising high-net-worth individuals who seek a structured and grounded understanding of:
-
The current state of venture capital in the U.S.
-
How Cyprus-based companies scale successfully into international markets
-
How disciplined early-stage investing is approached in practice
As a Cyprus-based venture firm with strong U.S. connectivity and network access, Kinisis Ventures operates at the intersection of both ecosystems.
The format is intimate and discussion-led, allowing for direct engagement with founders and the fund team.
Founder Perspectives: Scaling Beyond Cyprus
Hear directly from three founders building internationally
Threedium
Mike Charalambous
Building immersive 3D commerce infrastructure for global brands, with strong U.S. market activity.
Promed Bioscience
Dr. Costas Pitsillides
Expanding its advanced collagen-based biomaterials for the life sciences internationally, including U.S. commercial traction.
Embio Diagnostics
Constantinos Loizou
Developing portable diagnostic technology with international regulatory and market expansion focus.
Athlos House, Nicosia
26 March 2026
17:00 – 19:00
Attendance is limited to 20 participants.
Please confirm your participation by Friday, 20 March 2026.